Annual ROE
-3.49%
-3.96%-842.55%
December 31, 2024
Summary
- As of March 13, 2025, VNDA annual return on equity is -3.49%, with the most recent change of -3.96% (-842.55%) on December 31, 2024.
- During the last 3 years, VNDA annual ROE has fallen by -10.41% (-150.43%).
- VNDA annual ROE is now -110.37% below its all-time high of 33.67%, reached on December 31, 2019.
Performance
VNDA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-3.49%
-0.47%-15.56%
December 31, 2024
Summary
- As of March 13, 2025, VNDA quarterly return on equity is -3.49%, with the most recent change of -0.47% (-15.56%) on December 31, 2024.
- Over the past year, VNDA quarterly ROE has dropped by -2.59% (-287.78%).
- VNDA quarterly ROE is now -106.16% below its all-time high of 56.65%, reached on June 30, 2015.
Performance
VNDA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VNDA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -842.5% | -287.8% |
| 3 y3 years | -150.4% | -287.8% |
| 5 y5 years | -110.4% | -287.8% |
VNDA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -150.4% | at low | -150.5% | at low |
| 5 y | 5-year | -110.4% | at low | -110.0% | at low |
| alltime | all time | -110.4% | +98.4% | -106.2% | +98.6% |
Vanda Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -3.49%(-842.6%) | -3.49%(+15.6%) |
| Sep 2024 | - | -3.02%(+50.2%) |
| Jun 2024 | - | -2.01%(+123.3%) |
| Mar 2024 | - | -0.90%(-291.5%) |
| Dec 2023 | 0.47%(-61.5%) | 0.47%(-78.7%) |
| Sep 2023 | - | 2.21%(-22.2%) |
| Jun 2023 | - | 2.84%(-7.8%) |
| Mar 2023 | - | 3.08%(+150.4%) |
| Dec 2022 | 1.22%(-82.4%) | 1.23%(-4.7%) |
| Sep 2022 | - | 1.29%(-41.6%) |
| Jun 2022 | - | 2.21%(-40.1%) |
| Mar 2022 | - | 3.69%(-46.6%) |
| Dec 2021 | 6.92%(+28.1%) | 6.91%(-5.7%) |
| Sep 2021 | - | 7.33%(+2.8%) |
| Jun 2021 | - | 7.13%(0.0%) |
| Mar 2021 | - | 7.13%(+31.5%) |
| Dec 2020 | 5.40%(-84.0%) | 5.42%(+17.6%) |
| Sep 2020 | - | 4.61%(-84.2%) |
| Jun 2020 | - | 29.09%(-10.0%) |
| Mar 2020 | - | 32.34%(-7.0%) |
| Dec 2019 | 33.67%(+171.8%) | 34.76%(-13.6%) |
| Sep 2019 | - | 40.22%(+285.6%) |
| Jun 2019 | - | 10.43%(+26.7%) |
| Mar 2019 | - | 8.23%(-24.2%) |
| Dec 2018 | 12.39%(-204.6%) | 10.86%(+69.7%) |
| Sep 2018 | - | 6.40%(+776.7%) |
| Jun 2018 | - | 0.73%(-123.0%) |
| Mar 2018 | - | -3.18%(-73.3%) |
| Dec 2017 | -11.85%(-13.1%) | -11.92%(+8.2%) |
| Sep 2017 | - | -11.02%(+38.4%) |
| Jun 2017 | - | -7.96%(-24.2%) |
| Mar 2017 | - | -10.50%(-25.6%) |
| Dec 2016 | -13.63%(-49.8%) | -14.11%(-42.8%) |
| Sep 2016 | - | -24.67%(-19.4%) |
| Jun 2016 | - | -30.62%(+2.7%) |
| Mar 2016 | - | -29.82%(+11.0%) |
| Dec 2015 | -27.13% | -26.86%(-173.4%) |
| Sep 2015 | - | 36.60%(-35.4%) |
| Jun 2015 | - | 56.65%(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | 54.28%(+22.6%) |
| Dec 2014 | 19.70%(-125.3%) | 44.29%(-118.1%) |
| Sep 2014 | - | -244.67%(-3.3%) |
| Jun 2014 | - | -253.10%(+48.8%) |
| Mar 2014 | - | -170.08%(+86.7%) |
| Dec 2013 | -77.94%(-40.9%) | -91.12%(-23.4%) |
| Sep 2013 | - | -118.88%(-34.2%) |
| Jun 2013 | - | -180.75%(+13.1%) |
| Mar 2013 | - | -159.85%(+18.1%) |
| Dec 2012 | -131.94%(+379.3%) | -135.32%(+34.7%) |
| Sep 2012 | - | -100.43%(+28.9%) |
| Jun 2012 | - | -77.89%(+54.2%) |
| Mar 2012 | - | -50.51%(+93.7%) |
| Dec 2011 | -27.53%(-216.3%) | -26.07%(+373.1%) |
| Sep 2011 | - | -5.51%(-147.7%) |
| Jun 2011 | - | 11.54%(-42.9%) |
| Mar 2011 | - | 20.22%(-14.8%) |
| Dec 2010 | 23.67%(-122.8%) | 23.72%(-260.2%) |
| Sep 2010 | - | -14.81%(-73.3%) |
| Jun 2010 | - | -55.55%(-45.9%) |
| Mar 2010 | - | -102.60%(-8.7%) |
| Dec 2009 | -103.86%(+32.0%) | -112.42%(+24.0%) |
| Sep 2009 | - | -90.65%(+5.7%) |
| Jun 2009 | - | -85.79%(+12.1%) |
| Mar 2009 | - | -76.54%(-14.4%) |
| Dec 2008 | -78.71%(-41.3%) | -89.45%(-7.5%) |
| Sep 2008 | - | -96.68%(+0.3%) |
| Jun 2008 | - | -96.41%(+14.1%) |
| Mar 2008 | - | -84.48%(+21.4%) |
| Dec 2007 | -134.08%(-39.4%) | -69.57%(-1.6%) |
| Sep 2007 | - | -70.71%(-2.2%) |
| Jun 2007 | - | -72.28%(-29.2%) |
| Mar 2007 | - | -102.12%(-49.6%) |
| Dec 2006 | -221.21%(+115.8%) | -202.69%(+12.0%) |
| Sep 2006 | - | -180.94%(+7.0%) |
| Jun 2006 | - | -169.17%(+4.7%) |
| Mar 2006 | - | -161.60%(+107.5%) |
| Dec 2005 | -102.49%(>+9900.0%) | -77.89% |
| Dec 2004 | -0.38% | - |
FAQ
- What is Vanda Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual ROE year-on-year change?
- What is Vanda Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly ROE year-on-year change?
What is Vanda Pharmaceuticals annual return on equity?
The current annual ROE of VNDA is -3.49%
What is the all time high annual ROE for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual return on equity is 33.67%
What is Vanda Pharmaceuticals annual ROE year-on-year change?
Over the past year, VNDA annual return on equity has changed by -3.96% (-842.55%)
What is Vanda Pharmaceuticals quarterly return on equity?
The current quarterly ROE of VNDA is -3.49%
What is the all time high quarterly ROE for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly return on equity is 56.65%
What is Vanda Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, VNDA quarterly return on equity has changed by -2.59% (-287.78%)